[Activation of lipid peroxidation processes in chronic ischemic heart disease].
The content of lipid peroxidation products--hydroperoxides with conjugated double bonds and fluorescent compounds, which are formed on interaction of primary lipid peroxidation products and proteins, considerably increases in blood plasma of patients suffering from coronary heart disease. Treatment with combined vitamins E and C enables the blood plasma lipid peroxidation products to be decreased to a far greater extent as compared with conventional therapy.
D001205:Ascorbic Acid / Q000627:therapeutic use; D003327:Coronary Disease / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D008054:Lipid Peroxides / Q000097:blood*; D014810:Vitamin E / Q000627:therapeutic use
D008054:Lipid Peroxides; D014810:Vitamin E; D001205:Ascorbic Acid
Aktivatsiia protsessov perekisnogo okisleniia lipidov pri khronicheskoĭ ishemicheskoĭ bolezni serdtsa.